Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics awarded inducement grants to 43 new employees, consisting of an aggregate of 208,850 restricted stock units. The grants were made under the company’s 2024 Inducement Plan as a material inducement to employment, with one-third of the RSUs vesting annually over three years.
Key figures
- Shares Offered
- 208850
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.